137 related articles for article (PubMed ID: 16179731)
1. The HIV-1 Tat protein selectively enhances CXCR4 and inhibits CCR5 expression in megakaryocytic K562 cells.
Mondal D; Williams CA; Ali M; Eilers M; Agrawal KC
Exp Biol Med (Maywood); 2005 Oct; 230(9):631-44. PubMed ID: 16179731
[TBL] [Abstract][Full Text] [Related]
2. The HIV-1 Tat protein enhances megakaryocytic commitment of K562 cells by facilitating CREB transcription factor coactivation by CBP.
Williams CA; Mondal D; Agrawal KC
Exp Biol Med (Maywood); 2005 Dec; 230(11):872-84. PubMed ID: 16339753
[TBL] [Abstract][Full Text] [Related]
3. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
[TBL] [Abstract][Full Text] [Related]
4. Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance.
Chelucci C; Casella I; Federico M; Testa U; Macioce G; Pelosi E; Guerriero R; Mariani G; Giampaolo A; Hassan HJ; Peschle C
Blood; 1999 Sep; 94(5):1590-600. PubMed ID: 10477684
[TBL] [Abstract][Full Text] [Related]
5. Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures.
Antell GC; Dampier W; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; Schwartz G; Hershberg U; Krebs FC; Wigdahl B
Retrovirology; 2016 May; 13(1):32. PubMed ID: 27143130
[TBL] [Abstract][Full Text] [Related]
6. Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1.
Xiao H; Neuveut C; Tiffany HL; Benkirane M; Rich EA; Murphy PM; Jeang KT
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11466-71. PubMed ID: 11027346
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD4 controls the susceptibility of THP-1 cells to infection by R5 and X4 HIV type 1 isolates.
Konopka K; Düzgüneş N
AIDS Res Hum Retroviruses; 2002 Jan; 18(2):123-31. PubMed ID: 11839145
[TBL] [Abstract][Full Text] [Related]
8. Effect of HIV type 1 Tat protein on butyric acid-induced differentiation in a hematopoietic progenitor cell line.
Mondal D; Agrawal KC
AIDS Res Hum Retroviruses; 1996 Nov; 12(16):1529-36. PubMed ID: 8911578
[TBL] [Abstract][Full Text] [Related]
9. Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities.
Litovchick A; Lapidot A; Eisenstein M; Kalinkovich A; Borkow G
Biochemistry; 2001 Dec; 40(51):15612-23. PubMed ID: 11747436
[TBL] [Abstract][Full Text] [Related]
10. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
Bai J; Banda N; Lee NS; Rossi J; Akkina R
Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of tellimagrandin I on chemically induced differentiation of human leukemia K562 cells.
Yi Z; Wang Z; Li H; Liu M
Toxicol Lett; 2004 Mar; 147(2):109-19. PubMed ID: 14757314
[TBL] [Abstract][Full Text] [Related]
12. Biological significance of the expression of HIV-related chemokine coreceptors (CCR5 and CXCR4) and their ligands by human hematopoietic cell lines.
Majka M; Rozmyslowicz T; Honczarenko M; Ratajczak J; Wasik MA; Gaulton GN; Ratajczak MZ
Leukemia; 2000 Oct; 14(10):1821-32. PubMed ID: 11021758
[TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor potentiated the sodium butyrate- and PMA-induced megakaryocytic differentiation of K562 leukemia cells.
Xie P; Chan FS; Ip NY; Leung M
Leuk Res; 2000 Sep; 24(9):751-9. PubMed ID: 10978779
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat.
Ghezzi S; Noonan DM; Aluigi MG; Vallanti G; Cota M; Benelli R; Morini M; Reeves JD; Vicenzi E; Poli G; Albini A
Biochem Biophys Res Commun; 2000 Apr; 270(3):992-6. PubMed ID: 10772939
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 gp120 impairs the differentiation and survival of cord blood CD34+ HPCs induced to the erythroid lineage.
Morini S; Musumeci G; Bon I; Miserocchi A; Alviano F; Longo S; Bertoldi A; Velati CV; Gibellini D; Re MC
New Microbiol; 2016 Jan; 39(1):13-23. PubMed ID: 26922982
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
17. Coreceptor/chemokine receptor expression on human hematopoietic cells: biological implications for human immunodeficiency virus-type 1 infection.
Lee B; Ratajczak J; Doms RW; Gewirtz AM; Ratajczak MZ
Blood; 1999 Feb; 93(4):1145-56. PubMed ID: 9949156
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques.
Pauza CD; Trivedi P; Wallace M; Ruckwardt TJ; Le Buanec H; Lu W; Bizzini B; Burny A; Zagury D; Gallo RC
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3515-9. PubMed ID: 10725402
[TBL] [Abstract][Full Text] [Related]
19. Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression.
Missé D; Gajardo J; Oblet C; Religa A; Riquet N; Mathieu D; Yssel H; Veas F
AIDS; 2005 Jun; 19(9):897-905. PubMed ID: 15905670
[TBL] [Abstract][Full Text] [Related]
20. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
